nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRE—prostate gland—prostate cancer	0.0232	0.104	CbGeAlD
Alendronate—PTPN4—prostate gland—prostate cancer	0.0221	0.0993	CbGeAlD
Alendronate—PTPRS—prostate gland—prostate cancer	0.0189	0.0851	CbGeAlD
Alendronate—PTPRE—bone marrow—prostate cancer	0.012	0.0538	CbGeAlD
Alendronate—PTPN4—bone marrow—prostate cancer	0.0114	0.0512	CbGeAlD
Alendronate—ATP6V1A—prostate gland—prostate cancer	0.0109	0.0491	CbGeAlD
Alendronate—PTPRE—testis—prostate cancer	0.0102	0.046	CbGeAlD
Alendronate—PTPRS—bone marrow—prostate cancer	0.00975	0.0438	CbGeAlD
Alendronate—PTPN4—testis—prostate cancer	0.00973	0.0437	CbGeAlD
Alendronate—PTPRS—testis—prostate cancer	0.00834	0.0375	CbGeAlD
Alendronate—FDPS—prostate gland—prostate cancer	0.00822	0.037	CbGeAlD
Alendronate—ATP6V1A—renal system—prostate cancer	0.00744	0.0334	CbGeAlD
Alendronate—PTPRE—lymph node—prostate cancer	0.00741	0.0333	CbGeAlD
Alendronate—ATP6V1A—urethra—prostate cancer	0.00731	0.0328	CbGeAlD
Alendronate—PTPN4—lymph node—prostate cancer	0.00705	0.0317	CbGeAlD
Alendronate—FDPS—seminal vesicle—prostate cancer	0.00695	0.0313	CbGeAlD
Alendronate—PTPRS—lymph node—prostate cancer	0.00604	0.0272	CbGeAlD
Alendronate—ATP6V1A—bone marrow—prostate cancer	0.00562	0.0253	CbGeAlD
Alendronate—FDPS—renal system—prostate cancer	0.0056	0.0252	CbGeAlD
Alendronate—FDPS—urethra—prostate cancer	0.0055	0.0247	CbGeAlD
Alendronate—ATP6V1A—testis—prostate cancer	0.00481	0.0216	CbGeAlD
Alendronate—FDPS—bone marrow—prostate cancer	0.00424	0.019	CbGeAlD
Alendronate—FDPS—testis—prostate cancer	0.00362	0.0163	CbGeAlD
Alendronate—ATP6V1A—lymph node—prostate cancer	0.00349	0.0157	CbGeAlD
Alendronate—Histamine Phosphate—SLC22A3—prostate cancer	0.00317	0.369	CrCbGaD
Alendronate—FDPS—lymph node—prostate cancer	0.00263	0.0118	CbGeAlD
Alendronate—Histamine Phosphate—SLC22A1—prostate cancer	0.00227	0.265	CrCbGaD
Alendronate—Risedronate—PTGS2—prostate cancer	0.00125	0.145	CrCbGaD
Alendronate—Clodronate—PTGS2—prostate cancer	0.00111	0.129	CrCbGaD
Alendronate—Histamine Phosphate—CYP3A4—prostate cancer	0.000794	0.0924	CrCbGaD
Alendronate—Diarrhoea—Goserelin—prostate cancer	0.000362	0.000693	CcSEcCtD
Alendronate—Erythema multiforme—Docetaxel—prostate cancer	0.000359	0.000688	CcSEcCtD
Alendronate—Malaise—Etoposide—prostate cancer	0.000359	0.000687	CcSEcCtD
Alendronate—Constipation—Estradiol—prostate cancer	0.000358	0.000686	CcSEcCtD
Alendronate—Pain—Estradiol—prostate cancer	0.000358	0.000686	CcSEcCtD
Alendronate—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000358	0.000686	CcSEcCtD
Alendronate—Vertigo—Etoposide—prostate cancer	0.000358	0.000685	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000356	0.000681	CcSEcCtD
Alendronate—Dizziness—Goserelin—prostate cancer	0.00035	0.000669	CcSEcCtD
Alendronate—Erythema multiforme—Capecitabine—prostate cancer	0.000348	0.000666	CcSEcCtD
Alendronate—Dizziness—Conjugated Estrogens—prostate cancer	0.000346	0.000663	CcSEcCtD
Alendronate—Feeling abnormal—Estradiol—prostate cancer	0.000345	0.000661	CcSEcCtD
Alendronate—Dyspepsia—Mitoxantrone—prostate cancer	0.000344	0.000658	CcSEcCtD
Alendronate—Gastrointestinal pain—Estradiol—prostate cancer	0.000343	0.000656	CcSEcCtD
Alendronate—Dry skin—Epirubicin—prostate cancer	0.00034	0.00065	CcSEcCtD
Alendronate—Chest pain—Etoposide—prostate cancer	0.000339	0.000649	CcSEcCtD
Alendronate—Vomiting—Goserelin—prostate cancer	0.000336	0.000644	CcSEcCtD
Alendronate—Alopecia—Docetaxel—prostate cancer	0.000336	0.000643	CcSEcCtD
Alendronate—Discomfort—Etoposide—prostate cancer	0.000335	0.000641	CcSEcCtD
Alendronate—Pain—Mitoxantrone—prostate cancer	0.000334	0.000639	CcSEcCtD
Alendronate—Constipation—Mitoxantrone—prostate cancer	0.000334	0.000639	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000334	0.000639	CcSEcCtD
Alendronate—Rash—Goserelin—prostate cancer	0.000333	0.000638	CcSEcCtD
Alendronate—Dermatitis—Goserelin—prostate cancer	0.000333	0.000638	CcSEcCtD
Alendronate—Vomiting—Conjugated Estrogens—prostate cancer	0.000333	0.000637	CcSEcCtD
Alendronate—Urticaria—Estradiol—prostate cancer	0.000333	0.000637	CcSEcCtD
Alendronate—Abdominal pain—Estradiol—prostate cancer	0.000331	0.000634	CcSEcCtD
Alendronate—Body temperature increased—Estradiol—prostate cancer	0.000331	0.000634	CcSEcCtD
Alendronate—Headache—Goserelin—prostate cancer	0.000331	0.000634	CcSEcCtD
Alendronate—Erythema—Docetaxel—prostate cancer	0.000331	0.000633	CcSEcCtD
Alendronate—Rash—Conjugated Estrogens—prostate cancer	0.00033	0.000632	CcSEcCtD
Alendronate—Dermatitis—Conjugated Estrogens—prostate cancer	0.00033	0.000632	CcSEcCtD
Alendronate—Haemoglobin—Prednisone—prostate cancer	0.000329	0.000631	CcSEcCtD
Alendronate—Headache—Conjugated Estrogens—prostate cancer	0.000328	0.000628	CcSEcCtD
Alendronate—Gastritis—Epirubicin—prostate cancer	0.000328	0.000628	CcSEcCtD
Alendronate—Haemorrhage—Prednisone—prostate cancer	0.000328	0.000627	CcSEcCtD
Alendronate—Alopecia—Capecitabine—prostate cancer	0.000325	0.000622	CcSEcCtD
Alendronate—Dysgeusia—Docetaxel—prostate cancer	0.000324	0.00062	CcSEcCtD
Alendronate—Infection—Etoposide—prostate cancer	0.000323	0.000618	CcSEcCtD
Alendronate—Abdominal distension—Epirubicin—prostate cancer	0.000322	0.000617	CcSEcCtD
Alendronate—Feeling abnormal—Mitoxantrone—prostate cancer	0.000322	0.000616	CcSEcCtD
Alendronate—Erythema—Capecitabine—prostate cancer	0.00032	0.000613	CcSEcCtD
Alendronate—Asthma—Epirubicin—prostate cancer	0.00032	0.000613	CcSEcCtD
Alendronate—Dysphagia—Epirubicin—prostate cancer	0.00032	0.000613	CcSEcCtD
Alendronate—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000319	0.000611	CcSEcCtD
Alendronate—Muscle spasms—Docetaxel—prostate cancer	0.000318	0.000609	CcSEcCtD
Alendronate—Flatulence—Capecitabine—prostate cancer	0.000316	0.000604	CcSEcCtD
Alendronate—Dry skin—Doxorubicin—prostate cancer	0.000314	0.000602	CcSEcCtD
Alendronate—Nausea—Goserelin—prostate cancer	0.000314	0.000601	CcSEcCtD
Alendronate—Dysgeusia—Capecitabine—prostate cancer	0.000314	0.0006	CcSEcCtD
Alendronate—Nausea—Conjugated Estrogens—prostate cancer	0.000311	0.000596	CcSEcCtD
Alendronate—Urticaria—Mitoxantrone—prostate cancer	0.00031	0.000594	CcSEcCtD
Alendronate—Hypersensitivity—Estradiol—prostate cancer	0.000309	0.000591	CcSEcCtD
Alendronate—Abdominal pain—Mitoxantrone—prostate cancer	0.000309	0.000591	CcSEcCtD
Alendronate—Body temperature increased—Mitoxantrone—prostate cancer	0.000309	0.000591	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000309	0.000591	CcSEcCtD
Alendronate—Muscle spasms—Capecitabine—prostate cancer	0.000308	0.000589	CcSEcCtD
Alendronate—Anaemia—Docetaxel—prostate cancer	0.000306	0.000585	CcSEcCtD
Alendronate—Gastritis—Doxorubicin—prostate cancer	0.000303	0.000581	CcSEcCtD
Alendronate—Asthenia—Estradiol—prostate cancer	0.000301	0.000576	CcSEcCtD
Alendronate—Abdominal distension—Doxorubicin—prostate cancer	0.000298	0.000571	CcSEcCtD
Alendronate—Ill-defined disorder—Capecitabine—prostate cancer	0.000297	0.000569	CcSEcCtD
Alendronate—Pruritus—Estradiol—prostate cancer	0.000297	0.000568	CcSEcCtD
Alendronate—Dysphagia—Doxorubicin—prostate cancer	0.000296	0.000567	CcSEcCtD
Alendronate—Asthma—Doxorubicin—prostate cancer	0.000296	0.000567	CcSEcCtD
Alendronate—Anaemia—Capecitabine—prostate cancer	0.000296	0.000567	CcSEcCtD
Alendronate—Photosensitivity reaction—Epirubicin—prostate cancer	0.000292	0.00056	CcSEcCtD
Alendronate—Alopecia—Prednisone—prostate cancer	0.00029	0.000554	CcSEcCtD
Alendronate—Malaise—Capecitabine—prostate cancer	0.000289	0.000553	CcSEcCtD
Alendronate—Vertigo—Capecitabine—prostate cancer	0.000288	0.000551	CcSEcCtD
Alendronate—Hypersensitivity—Mitoxantrone—prostate cancer	0.000288	0.000551	CcSEcCtD
Alendronate—Diarrhoea—Estradiol—prostate cancer	0.000287	0.000549	CcSEcCtD
Alendronate—Erythema—Prednisone—prostate cancer	0.000285	0.000546	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000283	0.000542	CcSEcCtD
Alendronate—Myalgia—Docetaxel—prostate cancer	0.000282	0.000539	CcSEcCtD
Alendronate—Chest pain—Docetaxel—prostate cancer	0.000282	0.000539	CcSEcCtD
Alendronate—Asthenia—Mitoxantrone—prostate cancer	0.00028	0.000536	CcSEcCtD
Alendronate—Stomatitis—Epirubicin—prostate cancer	0.000278	0.000533	CcSEcCtD
Alendronate—Constipation—Etoposide—prostate cancer	0.000278	0.000532	CcSEcCtD
Alendronate—Pain—Etoposide—prostate cancer	0.000278	0.000532	CcSEcCtD
Alendronate—Dizziness—Estradiol—prostate cancer	0.000277	0.000531	CcSEcCtD
Alendronate—Chest pain—Capecitabine—prostate cancer	0.000273	0.000522	CcSEcCtD
Alendronate—Myalgia—Capecitabine—prostate cancer	0.000273	0.000522	CcSEcCtD
Alendronate—Photosensitivity reaction—Doxorubicin—prostate cancer	0.00027	0.000518	CcSEcCtD
Alendronate—Discomfort—Capecitabine—prostate cancer	0.000269	0.000516	CcSEcCtD
Alendronate—Infection—Docetaxel—prostate cancer	0.000268	0.000513	CcSEcCtD
Alendronate—Feeling abnormal—Etoposide—prostate cancer	0.000268	0.000512	CcSEcCtD
Alendronate—Diarrhoea—Mitoxantrone—prostate cancer	0.000267	0.000512	CcSEcCtD
Alendronate—Vomiting—Estradiol—prostate cancer	0.000266	0.00051	CcSEcCtD
Alendronate—Gastrointestinal pain—Etoposide—prostate cancer	0.000266	0.000509	CcSEcCtD
Alendronate—Ill-defined disorder—Prednisone—prostate cancer	0.000265	0.000507	CcSEcCtD
Alendronate—Rash—Estradiol—prostate cancer	0.000264	0.000506	CcSEcCtD
Alendronate—Dermatitis—Estradiol—prostate cancer	0.000264	0.000505	CcSEcCtD
Alendronate—Anaemia—Prednisone—prostate cancer	0.000264	0.000505	CcSEcCtD
Alendronate—Headache—Estradiol—prostate cancer	0.000263	0.000503	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000262	0.000501	CcSEcCtD
Alendronate—Angioedema—Prednisone—prostate cancer	0.000261	0.000499	CcSEcCtD
Alendronate—Infection—Capecitabine—prostate cancer	0.00026	0.000497	CcSEcCtD
Alendronate—Urticaria—Etoposide—prostate cancer	0.000258	0.000494	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—WNT4—prostate cancer	0.000258	0.00105	CbGpPWpGaD
Alendronate—Haemoglobin—Epirubicin—prostate cancer	0.000258	0.000493	CcSEcCtD
Alendronate—Stomatitis—Doxorubicin—prostate cancer	0.000257	0.000493	CcSEcCtD
Alendronate—Malaise—Prednisone—prostate cancer	0.000257	0.000493	CcSEcCtD
Alendronate—Abdominal pain—Etoposide—prostate cancer	0.000257	0.000492	CcSEcCtD
Alendronate—Body temperature increased—Etoposide—prostate cancer	0.000257	0.000492	CcSEcCtD
Alendronate—Vertigo—Prednisone—prostate cancer	0.000256	0.000491	CcSEcCtD
Alendronate—Haemorrhage—Epirubicin—prostate cancer	0.000256	0.000491	CcSEcCtD
Alendronate—ATP6V1A—Disease—LRP2—prostate cancer	0.000255	0.00103	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTAP—prostate cancer	0.000253	0.00103	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP7B1—prostate cancer	0.000253	0.00103	CbGpPWpGaD
Alendronate—Oedema peripheral—Epirubicin—prostate cancer	0.000252	0.000483	CcSEcCtD
Alendronate—ATP6V1A—Disease—P4HB—prostate cancer	0.00025	0.00101	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EIF2AK2—prostate cancer	0.00025	0.00101	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—RPL10—prostate cancer	0.00025	0.00101	CbGpPWpGaD
Alendronate—Nausea—Estradiol—prostate cancer	0.000249	0.000477	CcSEcCtD
Alendronate—Vomiting—Mitoxantrone—prostate cancer	0.000248	0.000475	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	0.000247	0.001	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SULT1E1—prostate cancer	0.000246	0.001	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SRD5A1—prostate cancer	0.000246	0.001	CbGpPWpGaD
Alendronate—Rash—Mitoxantrone—prostate cancer	0.000246	0.000471	CcSEcCtD
Alendronate—Dermatitis—Mitoxantrone—prostate cancer	0.000246	0.000471	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000246	0.000471	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—MC2R—prostate cancer	0.000246	0.000997	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—RALBP1—prostate cancer	0.000246	0.000997	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HIST1H2BG—prostate cancer	0.000246	0.000996	CbGpPWpGaD
Alendronate—Headache—Mitoxantrone—prostate cancer	0.000245	0.000468	CcSEcCtD
Alendronate—Myalgia—Prednisone—prostate cancer	0.000243	0.000465	CcSEcCtD
Alendronate—Erythema multiforme—Epirubicin—prostate cancer	0.000242	0.000464	CcSEcCtD
Alendronate—Discomfort—Prednisone—prostate cancer	0.00024	0.000459	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	0.000239	0.000971	CbGpPWpGaD
Alendronate—Hypersensitivity—Etoposide—prostate cancer	0.000239	0.000458	CcSEcCtD
Alendronate—Haemoglobin—Doxorubicin—prostate cancer	0.000238	0.000456	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000238	0.000456	CcSEcCtD
Alendronate—Dyspepsia—Docetaxel—prostate cancer	0.000238	0.000455	CcSEcCtD
Alendronate—ATP6V1A—Disease—NPPA—prostate cancer	0.000237	0.000962	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HIST1H4H—prostate cancer	0.000237	0.000962	CbGpPWpGaD
Alendronate—Haemorrhage—Doxorubicin—prostate cancer	0.000237	0.000454	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	0.000236	0.000956	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HSD17B3—prostate cancer	0.000235	0.000954	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ACSL4—prostate cancer	0.000235	0.000954	CbGpPWpGaD
Alendronate—Oedema peripheral—Doxorubicin—prostate cancer	0.000234	0.000447	CcSEcCtD
Alendronate—Asthenia—Etoposide—prostate cancer	0.000233	0.000446	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	0.000232	0.000942	CbGpPWpGaD
Alendronate—Nausea—Mitoxantrone—prostate cancer	0.000232	0.000444	CcSEcCtD
Alendronate—Infection—Prednisone—prostate cancer	0.000231	0.000443	CcSEcCtD
Alendronate—Pain—Docetaxel—prostate cancer	0.000231	0.000442	CcSEcCtD
Alendronate—Constipation—Docetaxel—prostate cancer	0.000231	0.000442	CcSEcCtD
Alendronate—Dyspepsia—Capecitabine—prostate cancer	0.00023	0.00044	CcSEcCtD
Alendronate—Pruritus—Etoposide—prostate cancer	0.00023	0.00044	CcSEcCtD
Alendronate—Alopecia—Epirubicin—prostate cancer	0.000226	0.000434	CcSEcCtD
Alendronate—FDPS—Metabolism—UMPS—prostate cancer	0.000225	0.000914	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ARG2—prostate cancer	0.000225	0.000914	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PHGDH—prostate cancer	0.000225	0.000914	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	0.000224	0.00091	CbGpPWpGaD
Alendronate—Erythema multiforme—Doxorubicin—prostate cancer	0.000224	0.000429	CcSEcCtD
Alendronate—Constipation—Capecitabine—prostate cancer	0.000224	0.000428	CcSEcCtD
Alendronate—Pain—Capecitabine—prostate cancer	0.000224	0.000428	CcSEcCtD
Alendronate—Erythema—Epirubicin—prostate cancer	0.000223	0.000427	CcSEcCtD
Alendronate—Feeling abnormal—Docetaxel—prostate cancer	0.000222	0.000426	CcSEcCtD
Alendronate—Diarrhoea—Etoposide—prostate cancer	0.000222	0.000426	CcSEcCtD
Alendronate—FDPS—Metabolism—LDHB—prostate cancer	0.000221	0.000896	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Docetaxel—prostate cancer	0.000221	0.000423	CcSEcCtD
Alendronate—Flatulence—Epirubicin—prostate cancer	0.00022	0.000421	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PENK—prostate cancer	0.000219	0.000889	CbGpPWpGaD
Alendronate—Dysgeusia—Epirubicin—prostate cancer	0.000218	0.000418	CcSEcCtD
Alendronate—FDPS—Metabolism—CYP3A5—prostate cancer	0.000217	0.00088	CbGpPWpGaD
Alendronate—Feeling abnormal—Capecitabine—prostate cancer	0.000215	0.000412	CcSEcCtD
Alendronate—Dizziness—Etoposide—prostate cancer	0.000215	0.000411	CcSEcCtD
Alendronate—Muscle spasms—Epirubicin—prostate cancer	0.000215	0.000411	CcSEcCtD
Alendronate—Gastrointestinal pain—Capecitabine—prostate cancer	0.000214	0.000409	CcSEcCtD
Alendronate—Body temperature increased—Docetaxel—prostate cancer	0.000213	0.000409	CcSEcCtD
Alendronate—Abdominal pain—Docetaxel—prostate cancer	0.000213	0.000409	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000212	0.000406	CcSEcCtD
Alendronate—FDPS—Metabolism—PDHA1—prostate cancer	0.00021	0.00085	CbGpPWpGaD
Alendronate—FDPS—Metabolism—UCP3—prostate cancer	0.00021	0.00085	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTA3—prostate cancer	0.00021	0.00085	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TCN2—prostate cancer	0.00021	0.00085	CbGpPWpGaD
Alendronate—Alopecia—Doxorubicin—prostate cancer	0.00021	0.000401	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GHR—prostate cancer	0.000209	0.000848	CbGpPWpGaD
Alendronate—Urticaria—Capecitabine—prostate cancer	0.000208	0.000398	CcSEcCtD
Alendronate—Ill-defined disorder—Epirubicin—prostate cancer	0.000207	0.000396	CcSEcCtD
Alendronate—Body temperature increased—Capecitabine—prostate cancer	0.000207	0.000396	CcSEcCtD
Alendronate—Abdominal pain—Capecitabine—prostate cancer	0.000207	0.000396	CcSEcCtD
Alendronate—Vomiting—Etoposide—prostate cancer	0.000207	0.000395	CcSEcCtD
Alendronate—Erythema—Doxorubicin—prostate cancer	0.000206	0.000395	CcSEcCtD
Alendronate—Anaemia—Epirubicin—prostate cancer	0.000206	0.000395	CcSEcCtD
Alendronate—Dyspepsia—Prednisone—prostate cancer	0.000205	0.000392	CcSEcCtD
Alendronate—Rash—Etoposide—prostate cancer	0.000205	0.000392	CcSEcCtD
Alendronate—Dermatitis—Etoposide—prostate cancer	0.000205	0.000392	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000204	0.000826	CbGpPWpGaD
Alendronate—Headache—Etoposide—prostate cancer	0.000204	0.00039	CcSEcCtD
Alendronate—Flatulence—Doxorubicin—prostate cancer	0.000203	0.000389	CcSEcCtD
Alendronate—Dysgeusia—Doxorubicin—prostate cancer	0.000202	0.000387	CcSEcCtD
Alendronate—ATP6V1A—Disease—B2M—prostate cancer	0.000202	0.000818	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFBR1—prostate cancer	0.000202	0.000818	CbGpPWpGaD
Alendronate—Malaise—Epirubicin—prostate cancer	0.000201	0.000385	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—NRP1—prostate cancer	0.0002	0.000813	CbGpPWpGaD
Alendronate—Vertigo—Epirubicin—prostate cancer	0.0002	0.000384	CcSEcCtD
Alendronate—FDPS—Metabolism—SLC22A3—prostate cancer	0.0002	0.000811	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HSD3B1—prostate cancer	0.0002	0.000811	CbGpPWpGaD
Alendronate—Constipation—Prednisone—prostate cancer	0.000199	0.000381	CcSEcCtD
Alendronate—Hypersensitivity—Docetaxel—prostate cancer	0.000199	0.000381	CcSEcCtD
Alendronate—Muscle spasms—Doxorubicin—prostate cancer	0.000198	0.00038	CcSEcCtD
Alendronate—ATP6V1A—Disease—RPS19—prostate cancer	0.000198	0.000805	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKR1C3—prostate cancer	0.000198	0.000805	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PRKACB—prostate cancer	0.000197	0.0008	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000194	0.000787	CbGpPWpGaD
Alendronate—Asthenia—Docetaxel—prostate cancer	0.000194	0.000371	CcSEcCtD
Alendronate—Nausea—Etoposide—prostate cancer	0.000193	0.000369	CcSEcCtD
Alendronate—Hypersensitivity—Capecitabine—prostate cancer	0.000193	0.000369	CcSEcCtD
Alendronate—ATP6V1A—Disease—PPP3CA—prostate cancer	0.000192	0.00078	CbGpPWpGaD
Alendronate—Feeling abnormal—Prednisone—prostate cancer	0.000192	0.000367	CcSEcCtD
Alendronate—FDPS—Metabolism—TBXAS1—prostate cancer	0.000192	0.000777	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTA4—prostate cancer	0.000192	0.000777	CbGpPWpGaD
Alendronate—Ill-defined disorder—Doxorubicin—prostate cancer	0.000192	0.000367	CcSEcCtD
Alendronate—Pruritus—Docetaxel—prostate cancer	0.000191	0.000366	CcSEcCtD
Alendronate—Anaemia—Doxorubicin—prostate cancer	0.000191	0.000365	CcSEcCtD
Alendronate—Gastrointestinal pain—Prednisone—prostate cancer	0.00019	0.000364	CcSEcCtD
Alendronate—Myalgia—Epirubicin—prostate cancer	0.00019	0.000364	CcSEcCtD
Alendronate—Chest pain—Epirubicin—prostate cancer	0.00019	0.000364	CcSEcCtD
Alendronate—Discomfort—Epirubicin—prostate cancer	0.000188	0.000359	CcSEcCtD
Alendronate—Asthenia—Capecitabine—prostate cancer	0.000188	0.000359	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000187	0.00076	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTA2—prostate cancer	0.000187	0.000757	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GNRH1—prostate cancer	0.000186	0.000756	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VIP—prostate cancer	0.000186	0.000756	CbGpPWpGaD
Alendronate—Malaise—Doxorubicin—prostate cancer	0.000186	0.000356	CcSEcCtD
Alendronate—ATP6V1A—Disease—PRKCZ—prostate cancer	0.000186	0.000755	CbGpPWpGaD
Alendronate—Vertigo—Doxorubicin—prostate cancer	0.000185	0.000355	CcSEcCtD
Alendronate—Urticaria—Prednisone—prostate cancer	0.000185	0.000354	CcSEcCtD
Alendronate—Pruritus—Capecitabine—prostate cancer	0.000185	0.000354	CcSEcCtD
Alendronate—Diarrhoea—Docetaxel—prostate cancer	0.000185	0.000354	CcSEcCtD
Alendronate—FDPS—Metabolism—ABCG5—prostate cancer	0.000184	0.000748	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SULT1A1—prostate cancer	0.000184	0.000748	CbGpPWpGaD
Alendronate—Body temperature increased—Prednisone—prostate cancer	0.000184	0.000352	CcSEcCtD
Alendronate—Abdominal pain—Prednisone—prostate cancer	0.000184	0.000352	CcSEcCtD
Alendronate—ATP6V1A—Disease—CALR—prostate cancer	0.000183	0.000742	CbGpPWpGaD
Alendronate—Infection—Epirubicin—prostate cancer	0.000181	0.000346	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—LPAR1—prostate cancer	0.00018	0.000732	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRP—prostate cancer	0.00018	0.000732	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTA1—prostate cancer	0.00018	0.000731	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGFR4—prostate cancer	0.00018	0.000729	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PARP1—prostate cancer	0.00018	0.000729	CbGpPWpGaD
Alendronate—Diarrhoea—Capecitabine—prostate cancer	0.000179	0.000342	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PLCB2—prostate cancer	0.000179	0.000725	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LRP2—prostate cancer	0.000179	0.000725	CbGpPWpGaD
Alendronate—Dizziness—Docetaxel—prostate cancer	0.000179	0.000342	CcSEcCtD
Alendronate—FDPS—Metabolism—HSD3B2—prostate cancer	0.000178	0.000723	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTO1—prostate cancer	0.000178	0.000723	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NAT2—prostate cancer	0.000178	0.000723	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CALCA—prostate cancer	0.000178	0.00072	CbGpPWpGaD
Alendronate—Myalgia—Doxorubicin—prostate cancer	0.000176	0.000336	CcSEcCtD
Alendronate—Chest pain—Doxorubicin—prostate cancer	0.000176	0.000336	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CX3CL1—prostate cancer	0.000175	0.000711	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—P4HB—prostate cancer	0.000175	0.000711	CbGpPWpGaD
Alendronate—Discomfort—Doxorubicin—prostate cancer	0.000174	0.000332	CcSEcCtD
Alendronate—Dizziness—Capecitabine—prostate cancer	0.000173	0.000331	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—HIST1H2BG—prostate cancer	0.000172	0.000698	CbGpPWpGaD
Alendronate—Vomiting—Docetaxel—prostate cancer	0.000172	0.000329	CcSEcCtD
Alendronate—Hypersensitivity—Prednisone—prostate cancer	0.000172	0.000328	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000171	0.000695	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PLCB2—prostate cancer	0.000171	0.000693	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LRP2—prostate cancer	0.000171	0.000693	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2C18—prostate cancer	0.000171	0.000693	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GRB7—prostate cancer	0.00017	0.000691	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDE4D—prostate cancer	0.00017	0.000691	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HSPA1A—prostate cancer	0.00017	0.00069	CbGpPWpGaD
Alendronate—Rash—Docetaxel—prostate cancer	0.00017	0.000326	CcSEcCtD
Alendronate—Dermatitis—Docetaxel—prostate cancer	0.00017	0.000326	CcSEcCtD
Alendronate—Headache—Docetaxel—prostate cancer	0.000169	0.000324	CcSEcCtD
Alendronate—FDPS—Metabolism—P4HB—prostate cancer	0.000168	0.000679	CbGpPWpGaD
Alendronate—Infection—Doxorubicin—prostate cancer	0.000167	0.00032	CcSEcCtD
Alendronate—Asthenia—Prednisone—prostate cancer	0.000167	0.00032	CcSEcCtD
Alendronate—Vomiting—Capecitabine—prostate cancer	0.000166	0.000318	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—HIST1H4H—prostate cancer	0.000166	0.000674	CbGpPWpGaD
Alendronate—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000166	0.000318	CcSEcCtD
Alendronate—Rash—Capecitabine—prostate cancer	0.000165	0.000316	CcSEcCtD
Alendronate—Pruritus—Prednisone—prostate cancer	0.000165	0.000315	CcSEcCtD
Alendronate—Dermatitis—Capecitabine—prostate cancer	0.000165	0.000315	CcSEcCtD
Alendronate—Headache—Capecitabine—prostate cancer	0.000164	0.000313	CcSEcCtD
Alendronate—ATP6V1A—Disease—CASP9—prostate cancer	0.000163	0.000662	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC22A1—prostate cancer	0.000163	0.000661	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GNG5—prostate cancer	0.000162	0.000658	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000162	0.000656	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.000161	0.000653	CbGpPWpGaD
Alendronate—Nausea—Docetaxel—prostate cancer	0.00016	0.000307	CcSEcCtD
Alendronate—Dyspepsia—Epirubicin—prostate cancer	0.00016	0.000307	CcSEcCtD
Alendronate—Diarrhoea—Prednisone—prostate cancer	0.000159	0.000305	CcSEcCtD
Alendronate—FDPS—Metabolism—SULT2A1—prostate cancer	0.000159	0.000644	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PRKCQ—prostate cancer	0.000158	0.000642	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MED12—prostate cancer	0.000156	0.000634	CbGpPWpGaD
Alendronate—Constipation—Epirubicin—prostate cancer	0.000156	0.000298	CcSEcCtD
Alendronate—Pain—Epirubicin—prostate cancer	0.000156	0.000298	CcSEcCtD
Alendronate—Nausea—Capecitabine—prostate cancer	0.000155	0.000297	CcSEcCtD
Alendronate—FDPS—Metabolism—GNG5—prostate cancer	0.000155	0.000629	CbGpPWpGaD
Alendronate—Dizziness—Prednisone—prostate cancer	0.000154	0.000295	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000154	0.000294	CcSEcCtD
Alendronate—ATP6V1A—Disease—FGF10—prostate cancer	0.00015	0.00061	CbGpPWpGaD
Alendronate—Feeling abnormal—Epirubicin—prostate cancer	0.00015	0.000287	CcSEcCtD
Alendronate—FDPS—Metabolism—NCOA3—prostate cancer	0.000149	0.000606	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Epirubicin—prostate cancer	0.000149	0.000285	CcSEcCtD
Alendronate—Dyspepsia—Doxorubicin—prostate cancer	0.000148	0.000284	CcSEcCtD
Alendronate—Vomiting—Prednisone—prostate cancer	0.000148	0.000283	CcSEcCtD
Alendronate—Rash—Prednisone—prostate cancer	0.000147	0.000281	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.000147	0.000595	CbGpPWpGaD
Alendronate—Dermatitis—Prednisone—prostate cancer	0.000147	0.000281	CcSEcCtD
Alendronate—Headache—Prednisone—prostate cancer	0.000146	0.000279	CcSEcCtD
Alendronate—Urticaria—Epirubicin—prostate cancer	0.000145	0.000277	CcSEcCtD
Alendronate—Pain—Doxorubicin—prostate cancer	0.000144	0.000276	CcSEcCtD
Alendronate—Constipation—Doxorubicin—prostate cancer	0.000144	0.000276	CcSEcCtD
Alendronate—Abdominal pain—Epirubicin—prostate cancer	0.000144	0.000276	CcSEcCtD
Alendronate—Body temperature increased—Epirubicin—prostate cancer	0.000144	0.000276	CcSEcCtD
Alendronate—ATP6V1A—Disease—TGFBR2—prostate cancer	0.000143	0.00058	CbGpPWpGaD
Alendronate—FDPS—Metabolism—HPGDS—prostate cancer	0.000142	0.000578	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2C19—prostate cancer	0.000142	0.000574	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTHLH—prostate cancer	0.000141	0.000573	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFBR1—prostate cancer	0.000141	0.000573	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ITPR1—prostate cancer	0.000141	0.000571	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKR1C3—prostate cancer	0.000139	0.000564	CbGpPWpGaD
Alendronate—Feeling abnormal—Doxorubicin—prostate cancer	0.000139	0.000266	CcSEcCtD
Alendronate—Nausea—Prednisone—prostate cancer	0.000138	0.000265	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PRKACB—prostate cancer	0.000138	0.000561	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ACHE—prostate cancer	0.000138	0.00056	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTT1—prostate cancer	0.000138	0.00056	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Doxorubicin—prostate cancer	0.000138	0.000264	CcSEcCtD
Alendronate—FDPS—Metabolism—CYP2A6—prostate cancer	0.000137	0.000554	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	0.000136	0.000552	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—THBS1—prostate cancer	0.000135	0.000546	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PPP3CA—prostate cancer	0.000135	0.000546	CbGpPWpGaD
Alendronate—Hypersensitivity—Epirubicin—prostate cancer	0.000134	0.000257	CcSEcCtD
Alendronate—Urticaria—Doxorubicin—prostate cancer	0.000134	0.000256	CcSEcCtD
Alendronate—Body temperature increased—Doxorubicin—prostate cancer	0.000133	0.000255	CcSEcCtD
Alendronate—Abdominal pain—Doxorubicin—prostate cancer	0.000133	0.000255	CcSEcCtD
Alendronate—FDPS—Metabolism—AKR1C3—prostate cancer	0.000133	0.000539	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ANXA1—prostate cancer	0.000133	0.000539	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PRKACB—prostate cancer	0.000132	0.000536	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP17A1—prostate cancer	0.000131	0.00053	CbGpPWpGaD
Alendronate—Asthenia—Epirubicin—prostate cancer	0.000131	0.00025	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PRKCZ—prostate cancer	0.00013	0.000529	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—LPL—prostate cancer	0.000129	0.000523	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	0.000129	0.000523	CbGpPWpGaD
Alendronate—Pruritus—Epirubicin—prostate cancer	0.000129	0.000247	CcSEcCtD
Alendronate—ATP6V1A—Disease—PDGFRB—prostate cancer	0.000128	0.000519	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PARP1—prostate cancer	0.000126	0.000511	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGFR4—prostate cancer	0.000126	0.000511	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOA2—prostate cancer	0.000125	0.000505	CbGpPWpGaD
Alendronate—Diarrhoea—Epirubicin—prostate cancer	0.000125	0.000239	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CALCA—prostate cancer	0.000124	0.000504	CbGpPWpGaD
Alendronate—Hypersensitivity—Doxorubicin—prostate cancer	0.000124	0.000238	CcSEcCtD
Alendronate—ATP6V1A—Disease—ERCC2—prostate cancer	0.000124	0.000501	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL12—prostate cancer	0.000121	0.000493	CbGpPWpGaD
Alendronate—Asthenia—Doxorubicin—prostate cancer	0.000121	0.000231	CcSEcCtD
Alendronate—ATP6V1A—Disease—ERBB3—prostate cancer	0.000121	0.00049	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGFR2—prostate cancer	0.000121	0.000489	CbGpPWpGaD
Alendronate—Dizziness—Epirubicin—prostate cancer	0.00012	0.000231	CcSEcCtD
Alendronate—Pruritus—Doxorubicin—prostate cancer	0.000119	0.000228	CcSEcCtD
Alendronate—FDPS—Metabolism—SLC5A5—prostate cancer	0.000119	0.000482	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MTHFR—prostate cancer	0.000116	0.000471	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP2E1—prostate cancer	0.000116	0.000471	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TERT—prostate cancer	0.000116	0.00047	CbGpPWpGaD
Alendronate—Vomiting—Epirubicin—prostate cancer	0.000116	0.000222	CcSEcCtD
Alendronate—Diarrhoea—Doxorubicin—prostate cancer	0.000115	0.000221	CcSEcCtD
Alendronate—FDPS—Metabolism—NQO1—prostate cancer	0.000115	0.000466	CbGpPWpGaD
Alendronate—Rash—Epirubicin—prostate cancer	0.000115	0.00022	CcSEcCtD
Alendronate—Dermatitis—Epirubicin—prostate cancer	0.000115	0.00022	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CASP9—prostate cancer	0.000114	0.000464	CbGpPWpGaD
Alendronate—Headache—Epirubicin—prostate cancer	0.000114	0.000218	CcSEcCtD
Alendronate—FDPS—Metabolism—TH—prostate cancer	0.000113	0.000459	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000112	0.000456	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP3A4—prostate cancer	0.000112	0.000454	CbGpPWpGaD
Alendronate—Dizziness—Doxorubicin—prostate cancer	0.000111	0.000213	CcSEcCtD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000111	0.000452	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRKCQ—prostate cancer	0.000111	0.000449	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NGFR—prostate cancer	0.000111	0.000449	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HIF1A—prostate cancer	0.000111	0.000449	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP1B1—prostate cancer	0.00011	0.000446	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAP3K7—prostate cancer	0.00011	0.000444	CbGpPWpGaD
Alendronate—Nausea—Epirubicin—prostate cancer	0.000108	0.000207	CcSEcCtD
Alendronate—ATP6V1A—Disease—CAV1—prostate cancer	0.000107	0.000435	CbGpPWpGaD
Alendronate—Vomiting—Doxorubicin—prostate cancer	0.000107	0.000205	CcSEcCtD
Alendronate—FDPS—Metabolism—GGT1—prostate cancer	0.000107	0.000432	CbGpPWpGaD
Alendronate—Rash—Doxorubicin—prostate cancer	0.000106	0.000203	CcSEcCtD
Alendronate—Dermatitis—Doxorubicin—prostate cancer	0.000106	0.000203	CcSEcCtD
Alendronate—Headache—Doxorubicin—prostate cancer	0.000106	0.000202	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—FGF10—prostate cancer	0.000105	0.000427	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NCOA1—prostate cancer	0.000105	0.000426	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ADRB2—prostate cancer	0.000104	0.000423	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP19A1—prostate cancer	0.000104	0.00042	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VAV3—prostate cancer	0.000102	0.000412	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—BAD—prostate cancer	0.000101	0.000409	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFBR2—prostate cancer	0.0001	0.000406	CbGpPWpGaD
Alendronate—Nausea—Doxorubicin—prostate cancer	0.0001	0.000192	CcSEcCtD
Alendronate—FDPS—Metabolism—RXRA—prostate cancer	9.99e-05	0.000405	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ITPR1—prostate cancer	9.86e-05	0.0004	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APC—prostate cancer	9.76e-05	0.000396	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.72e-05	0.000394	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGF—prostate cancer	9.65e-05	0.000391	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IRS1—prostate cancer	9.65e-05	0.000391	CbGpPWpGaD
Alendronate—FDPS—Metabolism—COMT—prostate cancer	9.62e-05	0.00039	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTP1—prostate cancer	9.58e-05	0.000388	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1R—prostate cancer	9.42e-05	0.000382	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ITPR1—prostate cancer	9.42e-05	0.000382	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—GSK3B—prostate cancer	9.37e-05	0.00038	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—EP300—prostate cancer	9.27e-05	0.000376	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—INS—prostate cancer	9.24e-05	0.000375	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CREBBP—prostate cancer	9.05e-05	0.000367	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LPL—prostate cancer	9.04e-05	0.000366	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PDGFRB—prostate cancer	8.95e-05	0.000363	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TYMS—prostate cancer	8.9e-05	0.000361	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GSTM1—prostate cancer	8.8e-05	0.000357	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ITGB3—prostate cancer	8.73e-05	0.000354	CbGpPWpGaD
Alendronate—FDPS—Metabolism—LPL—prostate cancer	8.64e-05	0.00035	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MAP2K1—prostate cancer	8.64e-05	0.00035	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CD—prostate cancer	8.58e-05	0.000348	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SERPINE1—prostate cancer	8.49e-05	0.000344	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ERBB3—prostate cancer	8.46e-05	0.000343	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGFR2—prostate cancer	8.45e-05	0.000343	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CYP1A1—prostate cancer	8.34e-05	0.000338	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ERCC2—prostate cancer	8.27e-05	0.000336	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—FGF2—prostate cancer	8.22e-05	0.000333	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TERT—prostate cancer	8.11e-05	0.000329	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOS3—prostate cancer	8.1e-05	0.000329	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—JAK2—prostate cancer	7.87e-05	0.000319	CbGpPWpGaD
Alendronate—FDPS—Metabolism—MTHFR—prostate cancer	7.78e-05	0.000315	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HIF1A—prostate cancer	7.76e-05	0.000315	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MDM2—prostate cancer	7.69e-05	0.000312	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARA—prostate cancer	7.63e-05	0.000309	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—ERBB2—prostate cancer	7.58e-05	0.000307	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—LEP—prostate cancer	7.57e-05	0.000307	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CAV1—prostate cancer	7.5e-05	0.000304	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CB—prostate cancer	7.48e-05	0.000303	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KDR—prostate cancer	7.42e-05	0.000301	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—prostate cancer	7.41e-05	0.000301	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ESR1—prostate cancer	7.23e-05	0.000293	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CAV1—prostate cancer	7.17e-05	0.000291	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—BAD—prostate cancer	7.06e-05	0.000286	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CDKN1B—prostate cancer	7.02e-05	0.000285	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.85e-05	0.000278	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CG—prostate cancer	6.83e-05	0.000277	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APC—prostate cancer	6.83e-05	0.000277	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGF—prostate cancer	6.76e-05	0.000274	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IRS1—prostate cancer	6.76e-05	0.000274	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CTNNB1—prostate cancer	6.63e-05	0.000269	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GSK3B—prostate cancer	6.56e-05	0.000266	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CG—prostate cancer	6.53e-05	0.000265	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CDKN1A—prostate cancer	6.48e-05	0.000263	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—INS—prostate cancer	6.47e-05	0.000262	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTEN—prostate cancer	6.46e-05	0.000262	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CREBBP—prostate cancer	6.34e-05	0.000257	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IGF1—prostate cancer	6.26e-05	0.000254	CbGpPWpGaD
Alendronate—FDPS—Metabolism—INS—prostate cancer	6.19e-05	0.000251	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EP300—prostate cancer	6.16e-05	0.00025	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CREBBP—prostate cancer	6.06e-05	0.000246	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MAP2K1—prostate cancer	6.05e-05	0.000245	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CD—prostate cancer	6.01e-05	0.000244	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SRC—prostate cancer	5.99e-05	0.000243	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SERPINE1—prostate cancer	5.94e-05	0.000241	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT3—prostate cancer	5.78e-05	0.000234	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—FGF2—prostate cancer	5.75e-05	0.000233	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CD—prostate cancer	5.74e-05	0.000233	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOS3—prostate cancer	5.67e-05	0.00023	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JAK2—prostate cancer	5.51e-05	0.000224	CbGpPWpGaD
Alendronate—FDPS—Metabolism—NOS3—prostate cancer	5.42e-05	0.00022	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MDM2—prostate cancer	5.38e-05	0.000218	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MYC—prostate cancer	5.37e-05	0.000218	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—prostate cancer	5.36e-05	0.000217	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ERBB2—prostate cancer	5.31e-05	0.000215	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGFR—prostate cancer	5.25e-05	0.000213	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CB—prostate cancer	5.24e-05	0.000212	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL8—prostate cancer	5.03e-05	0.000204	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CB—prostate cancer	5.01e-05	0.000203	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KRAS—prostate cancer	4.96e-05	0.000201	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—prostate cancer	4.96e-05	0.000201	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN1B—prostate cancer	4.91e-05	0.000199	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASP3—prostate cancer	4.82e-05	0.000195	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL2—prostate cancer	4.81e-05	0.000195	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCND1—prostate cancer	4.69e-05	0.00019	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CTNNB1—prostate cancer	4.64e-05	0.000188	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CA—prostate cancer	4.56e-05	0.000185	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—prostate cancer	4.55e-05	0.000185	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CDKN1A—prostate cancer	4.54e-05	0.000184	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTEN—prostate cancer	4.53e-05	0.000184	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTEN—prostate cancer	4.33e-05	0.000175	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EP300—prostate cancer	4.32e-05	0.000175	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SRC—prostate cancer	4.2e-05	0.00017	CbGpPWpGaD
Alendronate—FDPS—Metabolism—EP300—prostate cancer	4.13e-05	0.000167	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—prostate cancer	4.09e-05	0.000166	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT3—prostate cancer	4.05e-05	0.000164	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—IL6—prostate cancer	4.04e-05	0.000164	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MYC—prostate cancer	3.76e-05	0.000153	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—prostate cancer	3.75e-05	0.000152	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT1—prostate cancer	3.72e-05	0.000151	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGFR—prostate cancer	3.68e-05	0.000149	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KRAS—prostate cancer	3.48e-05	0.000141	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CA—prostate cancer	3.19e-05	0.000129	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—prostate cancer	3.09e-05	0.000125	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CA—prostate cancer	3.05e-05	0.000124	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IL6—prostate cancer	2.83e-05	0.000115	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT1—prostate cancer	2.61e-05	0.000106	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKT1—prostate cancer	2.49e-05	0.000101	CbGpPWpGaD
